Delivery Order SPE2DB22D2007-SPE2DB25FJ3RY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $1,599.60. The contract is classified as a Firm Fixed Price delivery order with an ultimate completion date of November 7, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Esomeprazole Magnesium Delayed Release 20 mg capsules (90-count) with a ceiling value of $3,592.33. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing pharmaceutical supply arrangements with the federal government. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $1,638.73. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,352.35 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $12,297.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract performance location is in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order valued at $3,701.91 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed Release 20 mg capsules (90-count) on October 28, 2025, with completion scheduled for October 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count units) under a firm fixed-price contract valued at $2,298.39. This non-set-aside delivery order is scheduled for completion by December 31, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a continuation of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,179.91 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) on October 22, 2025. This competitively awarded, non-set-aside order utilizes firm fixed pricing and is scheduled for completion by October 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the...
- The Defense Logistics Agency awarded a $1,064.58 delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count supply) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $2,972.37 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Esomeprazole Magnesium Delayed Release 20 mg capsules (90-count units). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3RYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count units) with a ceiling value of $5,332.08. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. The order is set for ultimate completion by August 7, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and other government healthcare systems. The company's substantial IDC vehicle supports global pharmaceutical supply needs for military healthcare programs, encompassing a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for gastric reflux medication reflects the company's core capability to rapidly fulfill pharmaceutical requirements for federal customers through its established supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 8/6/25 |